Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 499 participants.
Also called NCT02548455
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 499 participants
- Sponsor
- Registry
-
NCT02548455
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02548455. Allocation not applicable; no masking; primary purpose treatment. Start 2015-10-27 (actual); primary completion 2016-08-19 (actual). Results posted on 2018-05-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study
- Condition
- Heart Failure
- Intervention (Device)
- Quartet 1457Q LV Lead
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02548455- Content hash
749bed01e3c5227b7abb20c7492d14a792ba4e3ba3a4fced6c3c709b34ecca35